๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Lung resection for metastatic sarcomas: Total survival from primary treatment

โœ Scribed by Ugo Pastorino; Maurizio Valente; Marco Gasparini; Alberto Azzarelli; Armando Santoro; Marco Alloisio; Mauro Ongari; Luca Tavecchio; Gianni Ravasi


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
562 KB
Volume
40
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

โœฆ Synopsis


The results of surgical management of 63 cases of pulmonary metastases from bone and soft tissue sarcomas, admitted at the Istituto Nazionale Tumori of Milan, between 1970 and 1987, are reviewed in this paper. To estimate the relative impact of metastasectomy on the overall performance of treatment, survival curves were calculated from the time of first thoracotomy, as well as from the initial treatment of primary sarcoma. In the present series, total actuarial survival at 10 years was 37% for osteosarcoma, 27% for soft tissue sarcomas, and 24% for the other bone sarcomas, with a median survival of 48, 56, and 36 months, respectively. Five-year survival from the first pulmonary resection was influenced by the number of metastases and the length of the first disease-free interval only in osteosarcoma, while in soft tissue sarcomas a major untoward factor was represented by local recurrence at the site of the primary tumor. These data support the concept of pulmonary metastasectomy as effective salvage therapy for radically treated sarcomas; this management can rescue a significant proportion of all relapsed patients.


๐Ÿ“œ SIMILAR VOLUMES


Osteogenic sarcoma of the extremity with
โœ Gaetano Bacci; Mario Mercuri; Antonio Briccoli; Stefano Ferrari; Franco Bertoni; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 108 KB ๐Ÿ‘ 2 views

## Background: In the past 20 years, it has been demonstrated that the combination of surgery and chemotherapy improves the prognosis for patients with osteosarcoma of the extremity without detectable metastases at presentation. by contrast, the efficacy of chemotherapy coupled with aggressive surg